Blood News and Research

RSS

New studies demonstrate advantages of Masimo noninvasive and continuous measurements in ICUs

Masimo announced today that three new studies presented at the International Symposium of Intensive Care and Emergency Medicine (ISICEM) Annual Meeting in Brussels, Belgium, demonstrate the accuracy, reliability, and clinical impact of Masimo noninvasive and continuous measurements—noninvasive hemoglobin (SpHb®), Pleth Variability Index (PVI®), and Perfusion Index (PI)—in Intensive Care Unit (ICU) patients.

25 Mar 2011

Positive Phase 3 results from Tarsa's ORACAL study validates Unigene's oral peptide drug delivery technology

Unigene Laboratories, Inc. a leader in the design, delivery, manufacture and development of peptide-based therapeutics announced today that the statistically significant top-line results released by its licensee, Tarsa Therapeutics, validate its proprietary oral peptide drug delivery technology.

25 Mar 2011

Study: High intake of omega-3 fats can help prevent obesity-related chronic diseases

A study of Yup'ik Eskimos in Alaska, who on average consume 20 times more omega-3 fats from fish than people in the lower 48 states, suggests that a high intake of these fats helps prevent obesity-related chronic diseases such as diabetes and heart disease.

25 Mar 2011

Study: Short telomeres may predispose people to age-related diabetes

New evidence has emerged from studies in mice that short telomeres or "caps" at the ends of chromosomes may predispose people to age-related diabetes, according to Johns Hopkins scientists.

25 Mar 2011

New platinum coil technology makes minimally invasive surgery for brain aneurysms safer and cheaper

Loyola University Hospital is the first center in the Midwest to use new technology that makes minimally invasive surgery for life-threatening brain aneurysms significantly safer and cheaper.

25 Mar 2011

Dabigatran etexilate is less costly, more effective for stroke treatment in patients with AF

A new economic analysis, published online in Thrombosis and Haemostasis, suggested that Boehringer Ingelheim's novel oral direct thrombin inhibitor dabigatran etexilate is cost-effective compared to current treatment options, particularly in real-world clinical practice.

25 Mar 2011

DMC launches new procedure to protect diabetic patients with PAD from leg amputations

The Detroit Medical Center Cardiovascular Institute has implemented a ground-breaking new medical technology designed to protect patients with diabetes-related arterial disease from the risk of foot or leg amputation.

25 Mar 2011

VisualSonics introduces Vevo LAZR system to advance cancer research

VisualSonics Inc., a leader in real-time, in vivo, high-resolution micro-imaging systems and a wholly-owned subsidiary of SonoSite Inc., today announced the launch of the Vevo LAZR Photoacoustics Imaging system for the advancement of cancer research in the pre-clinical imaging market.

25 Mar 2011

Study finds risk of heart attack among patients with TIA

Patients who have suffered a "mini stroke" are at twice the risk of heart attack than the general population, according to research reported in Stroke: Journal of the American Heart Association.

25 Mar 2011

Brand Surgical Institute offers diabetic patients with life changing weight loss procedure

Millions of individuals all over the country suffer from obesity, preventing them from living an active lifestyle, as well as causing a number of health conditions, such as heart disease, diabetes, and high blood pressure.

25 Mar 2011

Columbia University, Sanofi-aventis collaborate to develop innovative diabetes medicines

Sanofi-aventis announced today a research collaboration with Columbia University Medical Center for the development of innovative diabetes medicines.

25 Mar 2011

FDA approves Medtronic's Consulta and Syncra pacemaker systems

Medtronic, Inc. today announced that the U.S. Food & Drug Administration has approved its Consulta and Syncra cardiac resynchronization therapy-pacemaker systems.

25 Mar 2011

Young adults with religious involvement more likely to become obese in middle-age

Could it be the potato salad? Young adults who frequently attend religious activities are 50 percent more likely to become obese by middle age as young adults with no religious involvement, according to new Northwestern Medicine research.

25 Mar 2011

HDL, BG Medicine to offer galectin-3 testing services for patients with heart failure

Health Diagnostic Laboratory, Inc. and BG Medicine, Inc., announced today an agreement under which HDL, Inc. will offer galectin-3 testing services based on the BG Medicine Galectin-3 Test.

25 Mar 2011

Scientists discover hormone pathway that can lead to new diabetes treatment

Researchers at UT Southwestern Medical Center have discovered a hormone pathway that potentially could lead to new ways of treating type 1 diabetes independent of insulin, long thought to be the sole regulator of carbohydrates in the liver.

25 Mar 2011

Sitagliptin drug can slow onset of diabetes

Diabetes type 2 is caused by insufficient levels of insulin to keep blood glucose under control. Excessive levels of another hormone, glucagon, can also contribute to diabetes type 2 by causing the liver to flood the body with stored glucose.

25 Mar 2011

Positive results from Tarsa's oral calcitonin Phase III trial against postmenopausal osteoporosis

Tarsa Therapeutics today announced that the Phase III ORACAL trial of its oral recombinant salmon calcitonin in the treatment of postmenopausal osteoporosis was successfully concluded and yielded statistically significant, positive top-line results.

25 Mar 2011

Diabetes management accepted for coverage by Chemical Abstracts

Future Medicine Ltd announces today that its new journal Diabetes Management (ISSN 1758-1907) which launched in January 2011 has been selected for coverage by Chemical Abstracts.

24 Mar 2011

DNA "end-caps" length linked to diabetes risk: New role for short telomeres

New evidence has emerged from studies in mice that short telomeres or “caps” at the ends of chromosomes may predispose people to age-related diabetes, according to Johns Hopkins scientists.

24 Mar 2011

Linköping doctor invents electroosmotic pump that can be placed in microfluidic chip

Advances in medical diagnostic technology will likely allow individuals to perform preliminary medical diagnoses themselves, in their own home, in the future.

24 Mar 2011

Blood News and Research

New studies demonstrate advantages of Masimo noninvasive and continuous measurements in ICUs

Positive Phase 3 results from Tarsa's ORACAL study validates Unigene's oral peptide drug delivery technology

Study: High intake of omega-3 fats can help prevent obesity-related chronic diseases

Study: Short telomeres may predispose people to age-related diabetes

New platinum coil technology makes minimally invasive surgery for brain aneurysms safer and cheaper

Dabigatran etexilate is less costly, more effective for stroke treatment in patients with AF

DMC launches new procedure to protect diabetic patients with PAD from leg amputations

VisualSonics introduces Vevo LAZR system to advance cancer research

Study finds risk of heart attack among patients with TIA

Brand Surgical Institute offers diabetic patients with life changing weight loss procedure

Columbia University, Sanofi-aventis collaborate to develop innovative diabetes medicines

FDA approves Medtronic's Consulta and Syncra pacemaker systems

Young adults with religious involvement more likely to become obese in middle-age

HDL, BG Medicine to offer galectin-3 testing services for patients with heart failure

Scientists discover hormone pathway that can lead to new diabetes treatment

Sitagliptin drug can slow onset of diabetes

Positive results from Tarsa's oral calcitonin Phase III trial against postmenopausal osteoporosis

Diabetes management accepted for coverage by Chemical Abstracts

DNA "end-caps" length linked to diabetes risk: New role for short telomeres

Linköping doctor invents electroosmotic pump that can be placed in microfluidic chip

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News